vendredi 21 décembre 2012

Press Review (December 22, 2012) – Revue de presse (22 décembre 2012)




Game changing diagnostic & prognostic prostate cancer genetic tests revealed by Jefferson
Researchers at the Kimmel Cancer Center at Jefferson have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes and distinguish clinically-relevant cancers.
In EurekAlert (press release)

Scientists Engineer Algae To Produce New Targeted Cancer Therapy
Next-generation cancer therapies are notoriously expensive. But maybe not for long.
By Emily Elert. In Popular Science

Cancer breakthrough: Disease depends on surrounding normal cells to spread, study finds
In a major breakthrough, Toronto scientists have discovered a new approach to cancer treatment that would target the “normal” cells embedded around tumours.
By Joseph Hall. In Toronto Star

Breast cancer photo projects on show at UAB Visual Arts Gallery
The University of Alabama at Birmingham (UAB) Visual Arts Gallery will present two powerful photographic projects on young women and breast cancer by fashion photographer David Jay Jan. 7-31, 2013.
By Shannon Thomason. In UAB News

Enzyme linked to prostate cancer may help identify lethal form of disease
Cancer researchers have identified an enzyme specifically linked to prostate cancer that they believe may help in early detection of an aggressive and deadly form of the disease.
By Noor Javed. In Toronto Star

MicroRNAs present exciting opportunities for cancer therapy and diagnosis
MicroRNA molecules potential biomarkers for early cancer detection, reports cancer biomarkers.
In EurekAlert (press release)

Coffee Drinking Linked With Lower Oral Cancer Death Risk: Study
As if there weren't already a host of other reasons to love coffee, a new study links drinking several cups a day with a decreased risk of dying from oral cancer.
In Huffington Post

Cancer News Blood cell gene fault linked to breast and ovarian cancer
Scientists have linked a rare genetic fault in the immune system to an increased risk of breast and ovarian cancers.
In Cancer Research UK

Poison for cancer cells: New method identifies active agents in mixtures of hundreds of substances
In their quest for new agents, pharmaceutical researchers test millions of substances all over the world. They like using color-forming reactions to identify new molecules. However, in intensively colored solutions or in the case of mixtures with multiple substances these tests fail. As part of his doctoral thesis, Martin Stein, member of staff at the Chair of Biochemistry at the Technische Universitaet Muenchen, developed a testing reaction based on magnetic resonance data. It helps find a specific pharmaceutical molecule among hundreds of different substances even in the most turbid of bacterial brews
In Medical XPress


Des boules de glace pour soigner le cancer du sein
Les patientes atteintes de cancer du sein pourraient être traitées sans chirurgie grâce au développement d'une technique qui détruit les tumeurs en les gelant.
Dans JOL Press (Blog)

Le café, un bon anti-cancer
Selon une récente étude américaine, boire régulièrement du café diminuerait considérablement le risque de développer des cancers de la bouche ou de la gorge.
Dans Aujourdhui.com

Cancer : les cellules tumorales ne supportent pas la pression !
L'allongement de la durée du traitement par tamoxifène en adjuvant à 10 ans permet de réduire le risque de récidive tardive du cancer du sein avec expression des récepteurs aux estrogènes (ER+) et améliore la survie, selon l'étude ATLAS (Adjuvant Tamoxifen - Longer Against Shorter) présentée au San Antonio Breast Cancer Symposium (SABCS) et publiée simultanément dans le Lancet.
Par Janlou Chaput. Dans Futura-Sciences  

Aider les patients sous chimio qui sont « dans le brouillard »‎
La médecine s'intéresse de plus en plus aux troubles cognitifs qui touchent temporairement certaines personnes traitées pour un cancer.
Par Pauline Fréour. Dans Le Figaro-Santé 

Cancer : des médicaments fabriqués grâce à des algues
Traditionnellement dédiée à la production de biocarburants, l'algue microspique Chlamydomonas reinhardtii permet de produire à moindre coût des protéines complexes utilisées dans le traitement de certains cancers.
Par Marc Mennessier. Dans Le Figaro-Santé 

Aucun commentaire:

Enregistrer un commentaire